InsidersTradesSigma
Follow the 3SBio Inc. share price and the full management transaction log of the company, a publicly traded company based in Hong Kong. Shares trade on HK HK, under the authority of HKEX. The latest transaction was filed on 9 June 2026 (Purchase). Among the most active insiders: Lou Jing. All data is free.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
3SBio Inc. is a Chinese biopharmaceutical company focused on the research, development, and commercialization of biological products. It primarily targets treatments for kidney diseases and blood disorders.